Immediate Impact
1 from Science/Nature 67 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of M.V. Bluthgen being referenced
Immune checkpoint inhibitors (IC) induce paradoxical progression in a subset of non-small cell lung cancer (NSCLC)
2016
Second-line combination therapies in nonsmall cell lung cancer without known driver mutations
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M.V. Bluthgen | 234 | 240 | 49 | 177 | 18 | 414 | |
| Lena Tran | 185 | 201 | 37 | 84 | 18 | 406 | |
| Sumi Yun | 118 | 211 | 23 | 148 | 22 | 457 | |
| Valentina Tateo | 133 | 189 | 36 | 91 | 31 | 390 | |
| Zhaofei Pang | 168 | 256 | 18 | 124 | 29 | 497 | |
| Kolette D. Fly | 230 | 175 | 36 | 71 | 15 | 449 | |
| M.C. Cox | 169 | 173 | 39 | 68 | 23 | 409 | |
| Simona Duranti | 144 | 228 | 16 | 98 | 26 | 425 | |
| Edmond P. Malaise | 127 | 186 | 18 | 183 | 15 | 459 | |
| Israel Cañadas | 207 | 283 | 27 | 103 | 11 | 476 | |
| Curt J. Essenburg | 106 | 148 | 57 | 76 | 16 | 404 |
All Works
Login with ORCID to disown or claim papers
Loading papers...